Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To estimate the best ORR based on investigator assessment using RECIST 1.1 of the TITAN regimen in untreated (1st line) and pretreated (2nd line) subjects with IMDC intermediate and high risk, advanced RCC with clear cell component
Critère d'inclusion
- subjects with previously untreated (1st line) or pretreated (2nd line), intermediate or high risk, advanced or metastatic renal cell carcinoma